General Surgical Oncology Department, IRCCS CRO di Aviano (Istituto Nazionale Tumori), Aviano, Italy.
General Surgery Department and Simulation Center, Department of Medicine, Academic Hospital of Udine, University of Udine, Udine, Italy.
Surg Today. 2024 Apr;54(4):291-309. doi: 10.1007/s00595-022-02639-9. Epub 2023 Jan 2.
Iatrogenic ureteral injury (IUI) during colorectal surgery is a rare complication but related to a serious burden of morbidity. This comprehensive and systematic review aims to provide a critical overview of the most recent literature about IUI prevention techniques in colorectal surgery. We performed a comprehensive and systematic review of studies published from 2000 to 2022 and assessed the use of techniques for ureteral injury prevention and intraoperative localization. 26 publications were included, divided into stent-based (prophylactic/lighted ureteral stent and near-infrared fluorescent ureteral catheter [PUS/LUS/NIRFUC]) and fluorescent dye (FD) groups. Costs, the percentage and number of IUIs detected, reported limitations, complication rates and other outcome points were compared. The IUI incidence rate ranged from 0 to 1.9% (mean 0.5%) and 0 to 1.2% (mean 0.3%) in the PUS/LUS/NIRFUC and FD groups, respectively. The acute kidney injury (AKI) and urinary tact infection (UTI) incidence rate ranged from 0.4 to 32.6% and 0 to 17.3%, respectively, in the PUS/LUS/NIRFUC group and 0-15% and 0-6.3%, respectively, in the FD group. Many other complications were also compared and descriptively analyzed (length-of-stay, mortality, etc.). These techniques appear to be feasible and safe in select patients with a high risk of IUI, but the delineation of reliable guidelines for preventing IUI will require more randomized controlled trials.
医源性输尿管损伤(IUI)是结直肠手术中罕见但与严重发病率相关的并发症。本综述旨在对结直肠手术中预防 IUI 技术的最新文献进行全面系统的回顾。我们对 2000 年至 2022 年发表的研究进行了全面系统的回顾,并评估了用于预防输尿管损伤和术中定位的技术的使用情况。共纳入 26 篇文献,分为支架(预防性/导光输尿管支架和近红外荧光输尿管导管 [PUS/LUS/NIRFUC])和荧光染料(FD)两组。比较了成本、IUIs 检出率、报告的局限性、并发症发生率和其他结局点。PUS/LUS/NIRFUC 组和 FD 组的 IUI 发生率分别为 0 至 1.9%(平均 0.5%)和 0 至 1.2%(平均 0.3%)。急性肾损伤(AKI)和尿路感染(UTI)发生率分别为 PUS/LUS/NIRFUC 组 0.4 至 32.6%和 0 至 17.3%,FD 组 0 至 15%和 0 至 6.3%。还比较并描述性分析了许多其他并发症(住院时间、死亡率等)。这些技术在高危 IUI 患者中似乎是可行且安全的,但需要更多的随机对照试验来制定可靠的预防 IUI 指南。